EU Pharma Figures - The Belgian biopharmaceutical sector is losing ground in European rankings

The latest EU Pharma Figures 2025 exhibit a worrying trend: Belgium’s position as a leader in the European  biopharmaceutical sector is under threat. We have slipped down the ranking on almost all indicators: employment opportunities, patent applications, R&D expenditures, and export. However, biopharmaceutical is still an innovative driving force for the manufacturing industry in our country, contributing 20 % of the added value. And that means Belgium cannot afford to lose a position that it has established through years of dedication and vision.